West Pharmaceutical Services, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WST research report →
Companywww.westpharma.com
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
- CEO
- Eric Green
- IPO
- 1980
- Employees
- 10,600
- HQ
- Exton, PA, US
Price Chart
Valuation
- Market Cap
- $21.49B
- P/E
- 40.36
- P/S
- 6.67
- P/B
- 7.32
- EV/EBITDA
- 26.64
- Div Yield
- 0.29%
Profitability
- Gross Margin
- 36.24%
- Op Margin
- 20.67%
- Net Margin
- 16.85%
- ROE
- 17.87%
- ROIC
- 15.24%
Growth & Income
- Revenue
- $3.07B · 6.26%
- Net Income
- $493.70M · 0.20%
- EPS
- $6.83 · 1.19%
- Op Income
- $617.40M
- FCF YoY
- 69.65%
Performance & Tape
- 52W High
- $330.88
- 52W Low
- $203.74
- 50D MA
- $272.96
- 200D MA
- $263.50
- Beta
- 1.17
- Avg Volume
- 892.06K
Get TickerSpark's AI analysis on WST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 12, 26 | Campbell Shane Alden | other | 473.593 |
| May 12, 26 | Campbell Shane Alden | other | 295.995 |
| May 12, 26 | Campbell Shane Alden | other | 473.593 |
| May 12, 26 | Campbell Shane Alden | other | 134.927 |
| May 12, 26 | Campbell Shane Alden | other | 295.995 |
| May 12, 26 | Campbell Shane Alden | other | 84.329 |
| May 4, 26 | Pucci Paolo | other | 791 |
| May 4, 26 | Michels Douglas A | other | 791 |
| May 4, 26 | Lockhart Stephen H | other | 791 |
| May 4, 26 | LAI GOLDMAN MYLA | other | 791 |
Our WST Coverage
We haven't published any research on WST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate WST Report →